{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "LOINC" in comments (approximate match)
Status:
US Previously Marketed
First approved in 1940
Class:
PROTEIN
Status:
US Previously Marketed
First marketed in 1921
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2024
Source:
M016
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M016
(2024)
Source URL:
First approved in 2024
Source:
M016
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT03169660: Phase 4 Interventional Completed Exudative Age-related Macular Degeneration
(2015)
Source URL:
First approved in 2023
Source:
DR.K CELL REPAIR GENIC AMPOULE by Noblesse Korea Co., Ltd.
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M020
(2022)
Source URL:
First approved in 2022
Source:
M020
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
BLA125659
(2021)
Source URL:
First approved in 2021
Source:
BLA125659
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2025)
Source URL:
First approved in 2015
Source:
Tonic Gel with horse chestnut and leech extract Horse Force by Zeldis-farma, Ooo
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
HUCORD HSCM-100 Ampoule by Hucord Co., Ltd.
(2015)
Source URL:
First approved in 2015
Source:
HUCORD HSCM-100 Ampoule by Hucord Co., Ltd.
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
First approved in 2015
Source:
21 CFR 355
Source URL:
Class:
PROTEIN
